Burma NE, Leduc-Pessah H, Fan CY, Trang T. Animal models of chronic pain: Advances and challenges for clinical translation. J Neurosci Res. 2017 ;95:1242-1256.
Galvez Mateos R. y Otros: Abordaje actual del dolor neuropático. Master line and prodigio S.L. 2003.
Kruger L: Methods in pain research. Colección: Methods and new frontiers in neuroscience. CRC press. 2001.
Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol. Rev., 53: 597-652, 2001.
Loeser JD, Butler SH, Chapman CR, Turk DC, editors. Bonica´s Management of pain. México: Mc Gram-Hill Interamericana, 3rd edition; 2003.
McMahon SB, Koltzenburg M, Tracey I, Turk DC, editors. Wall & Melzack's Textbook of Pain, 6th Edition. Philadelphia, PA: Elsevier Saunders; 2013: 541-552.
Mogil JS (2009) Animal models of pain: progress and challenges. Nat Rev Neurosci 10:283-294.
Mao J (2009). Translational pain research: achievements and challenges.J Pain 10:1001-11.
Nagakura Y. Giving priority to preclinical pain measures resistant to existing drugs for developing innovative analgesics. Drug Dev Res. 2018;79:147-156.
Taneja A, Della Pasqua O, Danhof M. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm. Eur J Clin Pharmacol. 2017;73:1219-1236.
Tappe-Theodor A, King T, Morgan MM. Pros and Cons of Clinically Relevant Methods to Assess Pain in Rodents. Neurosci Biobehav Rev. 2019;100:335-343
Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267-284.
Carbone L, Austin J. Pain and Laboratory Animals: Publication Practices for Better Data Reproducibility and Better Animal Welfare. PLoS One. 2016 May 12;11(5):e0155001.
Cendán CM, Pujalte JM, Portillo E, Baeyens JM. Antinociceptive effects of haloperidol and its metabolites in the formalin test. Psychopharmacology 182: 485-493, 2005
Entrena JM, Cobos EJ, Nieto FR, Cendán CM, Gris G, Del Pozo E, Zamanillo D, Baeyens JM. Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice. Pain 143(3):252-261,2009.
González-Cano R, Tejada MÁ, Artacho-Cordón A, et al. Effects of Tetrodotoxin in Mouse Models of Visceral Pain. Mar Drugs. 2017;15(6):188.
Hockley JR, González-Cano R, McMurray S, Tejada-Giraldez MA, McGuire C, Torres A, Wilbrey AL, Cibert-Goton V, Nieto FR, Pitcher T, Knowles CH, Baeyens JM, Wood JN, Winchester WJ, Bulmer DC, Cendán CM, McMurray G. Visceral and somatic pain modalities reveal NaV 1.7-independent visceral nociceptive pathways. J Physiol. 2017;595:2661-2679.
Nieto FR, Entrena JM, Cendán CM, Del Pozo E, Vela JM, Baeyens JM Tetrodotoxin inhibits the developoment and expression of neuropathic pain induced by paclitaxel in mice. Pain 137(3):520-31,2008
Vardeh D., Naranjo J.F. (2017) Peripheral and Central Sensitization. In: Yong R., Nguyen M., Nelson E., Urman R. (eds) Pain Medicine. Springer, Cham.
Woller SA, Eddinger KA, Corr M, Yaksh TL. An overview of pathways encoding nociception. Clin Exp Rheumatol. 2017;35 Suppl 107(5):40-46.
